PENSACOLA, FL, February 9, 2024 – ActiGraph, a leading provider of wearable technology and scientific services for academic research and clinical drug development, announced a new strategic partnership with Delve Health, a digital healthcare and clinical trials platform company that enables hybrid and decentralized clinical trials by partnering with sponsor organizations to match the right technology solutions with their trials.
Delve Health will be joining ActiGraph’s AccelerantTM partnership program. This program is designed to advance the use of digital health technologies (DHTs) in clinical development by simplifying CROs’ and technology vendors’ access to raw data streams. Delve Health’s multi-model platform provides worldwide access to digital healthcare and clinical trials. Their collaborative and customizable integration across mobile and web applications helps sponsors bring a patient-centric touch to hybrid and decentralized trials.
This partnership enables Delve Health and ActiGraph to work together to streamline the integration of ActiGraph’s wearable digital health technology into their platform. This would give sponsors access to remotely captured raw data and provide meaningful clinical insights from wearable digital health technologies.
"The focus of Delve Health on enabling a patient-centric clinical trial experience really resonates with the team here at ActiGraph,” says Jeremy Wyatt, CEO, ActiGraph. “We’re excited to work together to make trials more accessible and provide clinically meaningful data that accelerates the development of new treatments.”
"Joining ActiGraph's AccelerantTM partnership program marks a significant milestone for Delve Health as we continue to push the boundaries of what's possible in digital healthcare and clinical trials. This collaboration aligns perfectly with our mission to provide a seamless, patient-centric approach to clinical research by leveraging the latest in digital health technologies. By integrating ActiGraph’s cutting-edge wearable technology into our platform, we're not just simplifying access to raw data streams for CROs and technology vendors; we're also enhancing our ability to deliver meaningful insights that can accelerate clinical development and ultimately improve patient outcomes. Together, Delve Health and ActiGraph are setting a new standard for innovation in the realm of digital health, making it easier than ever for sponsors to harness the power of DHTs in their clinical trials." says Wessam Sonbol, CEO, Delve Health.
***
About ActiGraph
ActiGraph is pioneering the digital transformation of clinical research. We provide end-to-end digital health technology (DHT) solutions by integrating and operationalizing the best hardware, software, and algorithms to generate reliable evidence and get the right treatments to the right patients, faster. ActiGraph’s medical-grade wearable technology platform has been used to capture real-world, continuous digital measures of activity, sleep, and mobility for nearly 250 industry-sponsored clinical trials and thousands of academic research studies. Appearing in over 24,000 published scientific papers to date, ActiGraph is the most experienced and trusted wearable technology partner in the industry.
About Delve Health
Delve Health has been leading digital healthcare, hybrid and decentralized clinical trials (DCTs) with a multi-modal platform to provide a customizable solution. Our end-to-end platform is fully-configurable, which allows sponsors to pick and choose the necessary components for each individual study. This could be a combination of digital recruitment; patient engagement; eConsent; TeleVisit; ePRO/eCOA; site data capture; sensors; and analytics. Our global team of experts is committed to improving digital healthcare and eClinical solutions with a technology platform that patients want to use and healthcare professionals can trust. Delve Health is a privately held company, headquartered in Minneapolis, MN with remote offices in Illinois, Florida and Washington, DC, as well as a European office in the United Kingdom. For more information, visit: www.delvehealth.com
